EP3962457A4 - Composition cannabinoïde et procédés de fabrication - Google Patents
Composition cannabinoïde et procédés de fabrication Download PDFInfo
- Publication number
- EP3962457A4 EP3962457A4 EP19927176.8A EP19927176A EP3962457A4 EP 3962457 A4 EP3962457 A4 EP 3962457A4 EP 19927176 A EP19927176 A EP 19927176A EP 3962457 A4 EP3962457 A4 EP 3962457A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- manufacture
- processes
- cannabinoid composition
- cannabinoid
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Ceramic Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2019/053512 WO2020222029A1 (fr) | 2019-04-30 | 2019-04-30 | Composition cannabinoïde et procédés de fabrication |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3962457A1 EP3962457A1 (fr) | 2022-03-09 |
EP3962457A4 true EP3962457A4 (fr) | 2022-11-16 |
Family
ID=73028893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19927176.8A Withdrawn EP3962457A4 (fr) | 2019-04-30 | 2019-04-30 | Composition cannabinoïde et procédés de fabrication |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3962457A4 (fr) |
CA (1) | CA3138098A1 (fr) |
WO (1) | WO2020222029A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11857589B2 (en) * | 2018-09-19 | 2024-01-02 | Medpharm Holdings, Llc | Water-soluble, powdered cannabinoid and/or terpene extract |
US11596606B2 (en) | 2019-05-30 | 2023-03-07 | Metta Medical Inc | Activated cannabinoid controlled release compound tablet and method of forming the same |
JP2023535057A (ja) | 2020-07-21 | 2023-08-15 | ケムボー・エルエルシー | ジエステル化粧用配合物及びその使用 |
CZ310004B6 (cs) * | 2021-09-22 | 2024-05-01 | CB21 Pharma, s.r.o | Formulace kanabinoidů pro perorální podání |
WO2023250274A1 (fr) * | 2022-06-22 | 2023-12-28 | Ilera Therapeutics Llc | Matrice de capture et de dissolution améliorée pour cannabinoïdes et leurs procédés de fabrication |
WO2024059819A2 (fr) * | 2022-09-15 | 2024-03-21 | Tff Pharmaceuticals, Inc. | Compositions de cannabinoïdes pour administration par inhalation |
BE1031388B1 (fr) * | 2023-02-28 | 2024-09-25 | Silinnov Srl | Composition et forme galenique orale |
US20240316077A1 (en) * | 2023-03-21 | 2024-09-26 | Fertin Pharma A/S | Self-Emulsifying Systems For Cannabinoids |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120231083A1 (en) * | 2010-11-18 | 2012-09-13 | The Board Of Trustees Of The University Of Illinois | Sustained release cannabinoid medicaments |
US20180085308A1 (en) * | 2016-09-27 | 2018-03-29 | CannTab Therapeutics Limited | Sustained release cannabinoid formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160184258A1 (en) * | 2005-11-07 | 2016-06-30 | Murty Pharmaceuticals, Inc. | Oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
EP2282973A2 (fr) * | 2008-04-28 | 2011-02-16 | Formac Pharmaceuticals N.v. | Matériau à base de silice mésoporeuse ordonnée |
US20180263953A1 (en) * | 2016-09-27 | 2018-09-20 | CannTab Therapeutics, Limited | Sustained Release Cannabinoid Formulations |
-
2019
- 2019-04-30 EP EP19927176.8A patent/EP3962457A4/fr not_active Withdrawn
- 2019-04-30 CA CA3138098A patent/CA3138098A1/fr active Pending
- 2019-04-30 WO PCT/IB2019/053512 patent/WO2020222029A1/fr unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120231083A1 (en) * | 2010-11-18 | 2012-09-13 | The Board Of Trustees Of The University Of Illinois | Sustained release cannabinoid medicaments |
US20180085308A1 (en) * | 2016-09-27 | 2018-03-29 | CannTab Therapeutics Limited | Sustained release cannabinoid formulations |
Non-Patent Citations (3)
Title |
---|
CAROL A. MCCARTHY ET AL: "Role of Drug Adsorption onto the Silica Surface in Drug Release from Mesoporous Silica Systems", MOLECULAR PHARMACEUTICS, vol. 15, no. 1, 18 December 2017 (2017-12-18), US, pages 141 - 149, XP055757760, ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.7b00778 * |
FUJI CHEMICAL CO LTD: "Neusilin The Extraordinary Excipient for Oral Solid Dosage Forms", 1 November 2007 (2007-11-01), XP055969027, Retrieved from the Internet <URL:https://www.fujichemical.co.jp/english/newsletter/newsletter_pharma_0711.html> [retrieved on 20221007] * |
See also references of WO2020222029A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2020222029A1 (fr) | 2020-11-05 |
CA3138098A1 (fr) | 2020-11-05 |
EP3962457A1 (fr) | 2022-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3962457A4 (fr) | Composition cannabinoïde et procédés de fabrication | |
EP3962296A4 (fr) | Compositions de cannabinoïdes et procédés d'utilisation | |
EP3664796A4 (fr) | Composition de cannabinoïde enrichie en terpène et procédé de traitement | |
EP3990562A4 (fr) | Compositions adhésives et leurs procédés de fabrication | |
EP3886910A4 (fr) | Compositions comprenant un cannabinoïde ou un composé dérivé du cannabis, méthodes de fabrication et d'utilisation | |
EP4001305A4 (fr) | Anticorps anti-tau et son utilisation | |
EP4017538A4 (fr) | Compositions de cannabinoïdes, procédés de fabrication et utilisations de celles-ci | |
EP3980043A4 (fr) | Composition cannabinoïde thermogélifiante et son procédé de fabrication et d'utilisation | |
EP3840853A4 (fr) | Applications de cannabinoïdes connus et nouveaux | |
EP3946315A4 (fr) | Compositions de cannabinoïdes et leur utilisation | |
EP3806845A4 (fr) | Composition de cannabinoïdes et méthodes de traitement utilisant cette dernière | |
EP3897615A4 (fr) | Compositions de cannabis et méthodes | |
EP4006048A4 (fr) | Nouveau micropeptide hmmw et son application | |
EP4005561A4 (fr) | Préparation nanomicellaire d'icaritine et son procédé de préparation et son application | |
EP4031145A4 (fr) | Compositions de vésicules extracellulaires chargées en fenrétinide, compositions inhibitrices de vésicules extracellulaires chargées en c-kit, leurs procédés de préparation et utilisations associées | |
EP3897684A4 (fr) | Formulations de cannabinoïdes et leurs procédés de préparation | |
EP3911740A4 (fr) | Isoprénoïdes et leurs procédés de fabrication | |
EP4069772A4 (fr) | Composites kénaf-polyoléfine et procédés de préparation | |
EP4022700A4 (fr) | Matériaux et procédés de fabrication | |
EP3980534A4 (fr) | Production de molécules 2-hydroxyacyl-coa et leurs dérivés | |
EP3986488A4 (fr) | Composition adhésive et son procédé de production et d'utilisation | |
EP3988092A4 (fr) | Nouvelle application d'un complexe métallique | |
EP3972598A4 (fr) | Nouvelles utilisations du crénolanib | |
EP3920905A4 (fr) | Composition à base de cannabinoïde, ses procédés de préparation et d'utilisation | |
EP4081233A4 (fr) | Composition et procédés de fabrication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211022 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20221017 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 1/00 20060101ALI20221011BHEP Ipc: A23L 33/105 20160101ALI20221011BHEP Ipc: A61K 9/00 20060101ALI20221011BHEP Ipc: A61K 31/352 20060101ALI20221011BHEP Ipc: A61K 9/20 20060101ALI20221011BHEP Ipc: A61P 25/04 20060101ALI20221011BHEP Ipc: A61K 36/185 20060101ALI20221011BHEP Ipc: A61K 31/05 20060101ALI20221011BHEP Ipc: A61K 31/535 20060101ALI20221011BHEP Ipc: A61K 47/20 20060101ALI20221011BHEP Ipc: A61K 47/04 20060101ALI20221011BHEP Ipc: A61K 9/14 20060101AFI20221011BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230717 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20240130 |